These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3921856)

  • 1. Influence of MAO A and MAO B on the inactivation of noradrenaline in the saphenous vein of the dog.
    Caramona MM; Araújo D; Brandão F
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):401-6. PubMed ID: 3921856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of clorgyline and (-)deprenyl on the deamination of normetanephrine and noradrenaline in strips and homogenates of the canine saphenous vein.
    Caramona MM; Osswald W
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):396-400. PubMed ID: 3921855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deamination of released 3H-noradrenaline in the canine saphenous vein.
    Verbeuren TJ; Vanhoutte PM
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):148-57. PubMed ID: 7063044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a monoamine oxidase A inhibitor, FLA 668 (+) on the adrenergic mechanisms of the dog saphenous vein.
    Caramona MM; Esplugues JV; Osswald W
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):181-5. PubMed ID: 2935741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predominance of oxidative deamination in the metabolism of exogenous noradrenaline by the normal and chemically denervated human uterine artery.
    Branco D; Caramona M; Martel F; de Almeida JA; Osswald W
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep; 346(3):286-93. PubMed ID: 1407015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release and disposition of 3H-noradrenaline in the saphenous vein of neonate and adult dogs.
    Moura D; Vaz-da-Silva MJ; Azevedo I; Brandão F; Guimarães S
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Feb; 347(2):186-91. PubMed ID: 8474538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the mechanism of action of amezinium methylsulphate on the dog saphenous vein.
    Araújo D; Caramona MM; Osswald W
    Eur J Pharmacol; 1983 Jun; 90(2-3):203-14. PubMed ID: 6873182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of monoamine oxidase in the metabolism of exogenous noradrenaline by the human saphenous vein.
    Branco D; Caramona M; Araújo D; Osswald W
    Fundam Clin Pharmacol; 1992; 6(3):145-52. PubMed ID: 1628876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of MAO-A and MAO-B in the metabolic degradation of noradrenaline in human arteries.
    Figueiredo IV; Caramona M; Paiva MQ; Guimarães S
    J Auton Pharmacol; 1998 Apr; 18(2):123-8. PubMed ID: 9730267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine oxidase of types A and B in the saphenous vein and mesenteric artery of the dog.
    Caramona MM
    Naunyn Schmiedebergs Arch Pharmacol; 1982 May; 319(2):121-4. PubMed ID: 7110373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid iodide transport is reduced by administration of monoamine oxidase A inhibitors to rats.
    Cabanillas AM; Masini-Repiso AM; Costamagna ME; Pellizas C; Coleoni AH
    J Endocrinol; 1994 Nov; 143(2):303-8. PubMed ID: 7829993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A kinetic study of the release of noradrenaline by electrical stimulation: influence of presynaptic alpha-adrenoceptors.
    Brandão F; Davidson R; Monteiro JG
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):248-52. PubMed ID: 2984584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I; Youdim MB; Finberg JP
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra- and extraneuronal metabolism of 5-hydroxytryptamine in the isolated saphenous vein of the dog.
    Paiva MQ; Caramona M; Osswald W
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Jan; 325(1):62-8. PubMed ID: 6709075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].
    Severina IS; Klimova GI; Nersisian AA
    Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norepinephrine metabolism in canine saphenous vein: prevalence of glycol metabolites.
    Muldoon SM; Vanhoutte PM; Tyce GM
    Am J Physiol; 1978 Mar; 234(3):H235-43. PubMed ID: 629360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different effects of 1-methyl-4-phenyl-pyridinium (MPP+) on monoamine oxidase of dopaminergic terminals in caudate nucleus slices from pigmented and from albino rabbits.
    Lupp A; Lücking CH; Hedler L; Feuerstein TJ
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Feb; 347(2):141-6. PubMed ID: 8474535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the metabolic fate of noradrenaline released by electrical stimulation or by tyramine.
    Brandão F; Monteiro JG; Osswald W
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Oct; 305(1):37-40. PubMed ID: 723969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of MAO inhibitors on the high-affinity reuptake of biogenic amines in rat subcortical regions.
    Tekes K; Magyar K
    Neurobiology (Bp); 2000; 8(3-4):257-64. PubMed ID: 11225517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of monoamine oxidase activity on the release of noradrenaline by tyramine.
    Brandão F; Araújo D; Monteriro JG
    J Pharm Pharmacol; 1989 Oct; 41(10):729-32. PubMed ID: 2575157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.